Vaccine Info

VRC-ZKADNA090-00-VP Zika Virus Vaccine

Description

VRC-ZKADNA090-00-VP is a Zika virus wildtype DNA vaccine.

Indication

VRC-ZKADNA090-00-VP is indicated to prevent Zika virus infection.

Dosage

VRC-ZKADNA090-00-VP is administered as a 3-dose vaccination regimen. In the Phase 2 Clinical Trial, the vaccine candidate will be delivered intramuscularly by the PharmaJet needle-free device.

 

Updated
August 16th, 2019